Skip to main content Skip to main content
MRK · USPTO Filings

Merck & Co., Inc. — Patent Applications


Recent USPTO patent applications filed under applicant “Merck & Co., Inc. / MERCK & CO., INC.” — pending requests, not granted patents. Where a filing continues an already-granted parent, the parent’s number is shown.

50
Tracked Applications
2
Continuations of Granted Parents

Recent Applications

Every row is a patent application — a pending request, not a granted patent. “Granted Parent” shows the parent patent number when a filing continues an already-granted family. Newest filings first. Source: USPTO Open Data Portal (public).

TitleFiledApplication #StatusGranted Parent
METHODS FOR EMPLOYING MASS SPECTROMETRY TECHNIQUES TO SEQUENCE AND ANALYZE BIOLOGICAL MOLECULES2022-09-0663403984Provisional Application Expired
MULTIPLEXED INDUCTIVE IONIZATION SYSTEMS AND METHODS2019-05-3162855090Provisional Application Expired
ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS2017-05-2215601450Patented Caseparent 9657334
COMPOUNDS, COMPOSITIONS AND METHODS2014-12-2362096077Provisional Application Expired
ASSAYS FOR RESISTANCE TO ECHINOCANDIN-CLASS DRUGS2014-06-1614305499Patented Caseparent 8753819
LIVE, ATTENTUATED RESPIRATORY SYNCYTIAL VIRUS2009-11-03PCTUS2009063024RO PROCESSING COMPLETED-PLACED IN STORAGE
2,3-DISUBSTITUTED PIPERIDINE OREXIN RECEPTOR ANTAGONISTS2009-10-15PCTUS2009060759RO PROCESSING COMPLETED-PLACED IN STORAGE
3H-IMIDAZO[4,5-B]PYRIDIN-5-OL DERIVATIVES USEFUL IN THE TREATMENT OF GPR81 RECEPTOR DISORDERS2009-09-10PCTUS2009005083RO PROCESSING COMPLETED-PLACED IN STORAGE
NOVEL SUBSTITUTED AZABENZOXAZOLES2009-05-28PCTUS2009045376PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
OXAZOLOBENZIMIDAZOLE DERIVATIVES2009-05-08PCTUS2009043299RO PROCESSING COMPLETED-PLACED IN STORAGE
METHODS OF USING MIR210 AS A BIOMARKER FOR HYPOXIA AND AS A THERAPEUTIC AGENT FOR TREATING CANCER2009-04-16PCTUS2009040788RO PROCESSING COMPLETED-PLACED IN STORAGE
PANCREATIC BETA-CELL MASS BIOMARKER2009-04-10PCTUS2009040156RO PROCESSING COMPLETED-PLACED IN STORAGE
INTEGRIN TARGETING AGENTS AND METHODS OF USING SAME2009-03-13PCTUS2009037114RO PROCESSING COMPLETED-PLACED IN STORAGE
AHCY HYDROLASE INHIBITORS FOR TREATMENT OF HYPER HOMOCYSTEINEMIA2009-02-18PCTUS2009034344RO PROCESSING COMPLETED-PLACED IN STORAGE
TETRAHYDROTHIENO PYRIDINES2009-02-11PCTUS2009033718RO PROCESSING COMPLETED-PLACED IN STORAGE
PRODRUGS OF CGRP RECEPTOR ANTAGONIST2009-02-04PCTUS2009033008RO PROCESSING COMPLETED-PLACED IN STORAGE
P2X3 RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN2008-10-29PCTUS2008012271RO PROCESSING COMPLETED-PLACED IN STORAGE
P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN2008-10-29PCTUS2008012270RO PROCESSING COMPLETED-PLACED IN STORAGE
QUINOLIZIDINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS2008-10-15PCTUS2008011752RO PROCESSING COMPLETED-PLACED IN STORAGE
PEPTIDE COMPOUNDS FOR TREATING OBESITY AND INSULIN RESISTANCE2008-10-14PCTUS2008011733RO PROCESSING COMPLETED-PLACED IN STORAGE
MICRODRIVE AND MODULAR MICRODRIVE ASSEMBLY FOR POSITIONING INSTRUMENTS IN ANIMAL BODIES2008-09-03PCTUS2008075111RO PROCESSING COMPLETED-PLACED IN STORAGE
ANTIDIABETIC AZAINDOLES AND DIAZAINDOLES2008-06-25PCTUS2008007919RO PROCESSING COMPLETED-PLACED IN STORAGE
TRICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS2008-06-03PCTUS2008006964RO PROCESSING COMPLETED-PLACED IN STORAGE
CARBOXAMIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS2008-06-02PCTUS2008006958RO PROCESSING COMPLETED-PLACED IN STORAGE
ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657N2008-05-29PCTUS2008006791RO PROCESSING COMPLETED-PLACED IN STORAGE
PYRIDYL PIPERIDINE OREXIN RECEPTOR ANTAGONISTS2008-05-22PCTUS2008006563RO PROCESSING COMPLETED-PLACED IN STORAGE
CYCLOPROPYL PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS2008-05-19PCTUS2008006396RO PROCESSING COMPLETED-PLACED IN STORAGE
OXO BRIDGED DIAZEPAN OREXIN RECEPTOR ANTAGONISTS2008-05-14PCTUS2008006128RO PROCESSING COMPLETED-PLACED IN STORAGE
SPIROINDALONES2008-05-12PCTUS2008063365RO PROCESSING COMPLETED-PLACED IN STORAGE
METHOD OF TREATMENT USING FUSED AROMATIC COMPOUNDS HAVING ANTI-DIABETIC ACTIVITY2008-05-02PCTUS2008005726RO PROCESSING COMPLETED-PLACED IN STORAGE
2-SUBSTITUTED INDOLE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS2008-04-22PCTUS2008005156PCT - IPER (International Preliminary Examination Report) 409-416 Mailed
TRIAZOLE DERIVATIVES WHICH ARE SMO ANTAGONISTS2008-04-15PCTUS2008004862RO PROCESSING COMPLETED-PLACED IN STORAGE
NOVEL 1,8-NAPHTHYRIDINE COMPOUNDS2008-04-14PCTUS2008004817RO PROCESSING COMPLETED-PLACED IN STORAGE
ARYL HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS2008-04-11PCTUS2008004786RO PROCESSING COMPLETED-PLACED IN STORAGE
BICYCLIC ANILIDE HETEROCYCLIC CGRP RECEPTOR ANTAGONISTS2008-04-11PCTUS2008004694RO PROCESSING COMPLETED-PLACED IN STORAGE
CGRP RECEPTOR ANTAGONISTS WITH TERTIARY AMIDE, SULFONAMIDE, CARBAMATE AND UREA END GROUPS2008-04-07PCTUS2008004528RO PROCESSING COMPLETED-PLACED IN STORAGE
SUBSTITUTED FURO[2,3-B] PYRIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS2008-04-07PCTUS2008004533RO PROCESSING COMPLETED-PLACED IN STORAGE
ISOLATED NUCLEIC ACID MOLECULES CORRESPONDING TO MICRO RNA 145 (MIRNA-145) AND THEIR USE IN TREATING COLON CANCER2008-04-07PCTUS2008004536RO PROCESSING COMPLETED-PLACED IN STORAGE
THERAPEUTIC AGENTS2008-04-03PCTUS2008004336RO PROCESSING COMPLETED-PLACED IN STORAGE
ANTI-HYPERCHOLESTEROLEMIC COMPOUND2008-03-28PCTUS2008004140RO PROCESSING COMPLETED-PLACED IN STORAGE
BROADLY REPRESENTATIVE ANTIGEN SEQUENCES AND METHOD FOR SELECTION2008-03-26PCTUS2008003947RO PROCESSING COMPLETED-PLACED IN STORAGE
COMBINATION THERAPY FOR THE TREATMENT-OF LOWER URINARY TRACT SYMPTOMS2008-03-25PCTUS2008003873RO PROCESSING COMPLETED-PLACED IN STORAGE
SUBSTITUTED PYRIDO[3,2-E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS2008-03-24PCTUS2008003847RO PROCESSING COMPLETED-PLACED IN STORAGE
SUBSTITUTED PYRIDO [2, 3-D] PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS2008-03-24PCTUS2008003848RO PROCESSING COMPLETED-PLACED IN STORAGE
METHOD FOR DETECTING AUTOPROCESSED, SECRETED PCSK92008-03-21PCTUS2008003800RO PROCESSING COMPLETED-PLACED IN STORAGE
MINERALOCORTICOID RECEPTOR MODULATORS2008-03-19PCTUS2008003600RO PROCESSING COMPLETED-PLACED IN STORAGE
POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS EPIDERMIDIS2008-03-14PCTUS2008003389RO PROCESSING COMPLETED-PLACED IN STORAGE
METHODS FOR MONITORING GAMMA SECRETASE INHIBITION IN VIVO2008-03-11PCTUS2008003238RO PROCESSING COMPLETED-PLACED IN STORAGE
INHIBITORS OF JANUS KINASES AND/OR 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-12008-03-10PCTUS2008003206RO PROCESSING COMPLETED-PLACED IN STORAGE
MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS2008-03-07PCTUS2008003078RO PROCESSING COMPLETED-PLACED IN STORAGE

How to read this

Every row here is an application — a request the USPTO has not yet decided. In plain English: these filings show where Merck & Co., Inc.’s R&D effort is pointed right now, often 18–24 months before any product ships — but an application can be amended, abandoned, or rejected, and most confer no enforceable rights until granted. A “granted parent” tag means the filing continues a patent family that already has a grant — the new claims themselves are still pending. Filings are matched by applicant name, so work filed under subsidiary or research-entity names may not appear. Source: USPTO Open Data Portal (public).